BRANFORD, Conn., Aug. 22 /PRNewswire-FirstCall/ -- CAS Medical Systems,
Inc. (Nasdaq: CASM), a medical device company focused on innovative
non-invasive vital signs monitoring, announced today that Andrew Kersey,
Chief Operating Officer and Jeffery Baird, Chief Financial Officer will be
presenting an overview of the Company at the Roth Capital Partners Leaders
in Small and Micro-Cap Markets Conference in New York City, Thursday,
September 7, 2006 at 2:30 pm Eastern Time. The conference is being held at
the Westin New York in Times Square, New York City.
Mr. Kersey and Mr. Baird will provide a brief corporate overview and
discuss the Company's Cerebral Oximeter, FORE-SIGHT(TM), which is planned
for launch by the end of 2006. The FORE-SIGHT Cerebral Oximeter measures
absolute cerebral tissue oxygen saturation and provides new information
that allows clinicians to monitor and quickly respond to instances of brain
tissue oxygen deprivation before damage to the brain occurs.
The presentation will also be broadcast live over the Internet, and
will be accessible until October 7 on the Company's website at
http://www.casmed.com. Please allow extra time prior to the call to visit
the site and download the streaming media software required to listen to
the Internet broadcast.
About CAS Medical Systems, Inc.
Founded in 1984, CAS Medical Systems, Inc. (CASMED(TM)) is dedicated to
the design and manufacture of innovative technologies and products vital to
patient care in the most challenging clinical environments. Its current
product lines include blood pressure measurement technology, vital signs
monitoring equipment, blood pressure cuffs, apnea monitoring equipment and
products for neonatal intensive care. With a reputation for the highest
quality products available in the markets it serves, CASMED products are
used by clinicians worldwide.
For more information contact:
ir@casmed.com
Investors Media
Financial Dynamics Financial Dynamics
John Capodanno Robert Stanislaro
212-850-5705 212-850-5657
jcapodanno@fd-us.com rstanislaro@fd-us.com
Statements included in this press release, which are not historical in
nature, are forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Statements relating to the future financial performance of the Company are
subject to many factors including, but not limited to, the customer
acceptance of the products in the market, the introduction of competitive
products and product development, commercialization and technological
difficulties, and other risks detailed in the Company's Securities and
Exchange Commission filings.
Such statements are based upon the current beliefs and expectations of
the Company's management and are subject to significant risks and
uncertainties. Actual results may differ from those set forth in the
forward-looking statements. When used in this press release the terms
"anticipate," "believe," "estimate," "expect," "may," "objective," "plan,"
"possible," "potential," "project," "will" and similar expressions identify
forward-looking statements. The forward-looking statements contained in
this press release are made as of the date hereof, and we do not undertake
any obligation to update any forward- looking statements, whether as a
result of future events, new information or otherwise.
SOURCE CAS Medical Systems, Inc.
 back to top
Related links:
http://www.casmed.com
CONTACT:
Investors, ir@casmed.com, or John Capodanno,
+1-212-850-5705, jcapodanno@fd-us.com, or Media, Robert
Stanislaro, +1-212-850-5657, rstanislaro@fd-us.com, both of
Financial Dynamics, for CAS Medical Systems
|
